Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2016, Article ID 3970942, 11 pages
http://dx.doi.org/10.1155/2016/3970942
Research Article

In Vivo Tracking of Systemically Administered Allogeneic Bone Marrow Mesenchymal Stem Cells in Normal Rats through Bioluminescence Imaging

1Institute of Disaster Medicine and Public Health, Affiliated Hospital of Logistic University of Chinese People’s Armed Police Force, Tianjin, China
2Key Laboratory of Emergency and Disaster Medicine in Chinese People’s Liberation Army (PLA), Tianjin 300162, China
3Department of Pathology, Affiliated Hospital of Logistic University of Chinese People’s Armed Police Force, Tianjin, China

Received 22 March 2016; Revised 26 May 2016; Accepted 3 July 2016

Academic Editor: Ping Wang

Copyright © 2016 Juan Cao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. J. Jones and S. J. McTaggart, “Immunosuppression by mesenchymal stromal cells: from culture to clinic,” Experimental Hematology, vol. 36, no. 6, pp. 733–741, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. M. R. Reagan and D. L. Kaplan, “Concise review: mesenchymal stem cell tumor-homing: detection methods in disease model systems,” Stem Cells, vol. 29, no. 6, pp. 920–927, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. I. B. Resnick, C. Barkats, M. Y. Shapira et al., “Treatment of severe steroid resistant acute GVHD with mesenchymal stromal cells (MSC),” American Journal of Blood Research, vol. 3, no. 3, pp. 225–238, 2013. View at Google Scholar
  4. M. Introna, G. Lucchini, E. Dander et al., “Treatment of graft versus host disease with mesenchymal stromal cells: a phase I study on 40 adult and pediatric patients,” Biology of Blood and Marrow Transplantation, vol. 20, no. 3, pp. 375–381, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Bartunek, A. Behfar, D. Dolatabadi et al., “Cardiopoietic stem cell therapy in heart failure: the C-CURE (Cardiopoietic stem Cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologics,” Journal of the American College of Cardiology, vol. 61, no. 23, pp. 2329–2338, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Karamouzian, S. N. Nematollahi-Mahani, N. Nakhaee, and H. Eskandary, “Clinical safety and primary efficacy of bone marrow mesenchymal cell transplantation in subacute spinal cord injured patients,” Clinical Neurology and Neurosurgery, vol. 114, no. 7, pp. 935–939, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Forostyak, P. Jendelova, and E. Sykova, “The role of mesenchymal stromal cells in spinal cord injury, regenerative medicine and possible clinical applications,” Biochimie, vol. 95, no. 12, pp. 2257–2270, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. M.-E. M. Amer, S. Z. El-Sayed, W. A. El-Kheir et al., “Clinical and laboratory evaluation of patients with end-stage liver cell failure injected with bone marrow-derived hepatocyte-like cells,” European Journal of Gastroenterology and Hepatology, vol. 23, no. 10, pp. 936–941, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Skrahin, R. K. Ahmed, G. Ferrara et al., “Autologous mesenchymal stromal cell infusion as adjunct treatment in patients with multidrug and extensively drug-resistant tuberculosis: an open-label phase 1 safety trial,” The Lancet Respiratory Medicine, vol. 2, no. 2, pp. 108–122, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. J. G. Wilson, K. D. Liu, H. Zhuo et al., “Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial,” The Lancet Respiratory Medicine, vol. 3, no. 1, pp. 24–32, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. J. R. D. Wet, K. V. Wood, D. R. Helinski, and M. DeLuca, “Cloning of firefly luciferase cDNA and the expression of active luciferase in Escherichia coli,” Proceedings of the National Academy of Sciences of the United States of America, vol. 82, no. 23, pp. 7870–7873, 1985. View at Publisher · View at Google Scholar · View at Scopus
  12. K.-S. Jang, K.-S. Lee, S.-H. Yang, and S.-S. Jeun, “In vivo tracking of transplanted bone marrow-derived mesenchymal stem cells in a murine model of stroke by bioluminescence imaging,” Journal of Korean Neurosurgical Society, vol. 48, no. 5, pp. 391–398, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Xia and J. Cao, “Imaging the survival and utility of pre-differentiated allogeneic MSC in ischemic heart,” Biochemical and Biophysical Research Communications, vol. 438, no. 2, pp. 382–387, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. W. Zhuo, L. Liao, Y. Fu et al., “Efficiency of endovenous versus arterial administration of mesenchymal stem cells for ischemia-reperfusion-induced renal dysfunction in rats,” Transplantation Proceedings, vol. 45, no. 2, pp. 503–510, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. M. E. Aanstoos, D. P. Regan, R. J. Rose, L. S. Chubb, and N. P. Ehrhart, “Do mesenchymal stromal cells influence microscopic residual or metastatic osteosarcoma in a murine model?” Clinical Orthopaedics and Related Research, vol. 474, no. 3, pp. 707–715, 2016. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Dominici, K. Le Blanc, I. Mueller et al., “Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement,” Cytotherapy, vol. 8, no. 4, pp. 315–317, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Tyndall, “Mesenchymal stem cell treatments in rheumatology—a glass half full?” Nature Reviews Rheumatology, vol. 10, no. 2, pp. 117–124, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. F. Gao, S. M. Chiu, D. A. Motan et al., “Mesenchymal stem cells and immunomodulation: current status and future prospects,” Cell Death and Disease, vol. 7, no. 1, Article ID e2062, 2016. View at Publisher · View at Google Scholar
  19. S. Kidd, E. Spaeth, J. L. Dembinski et al., “Direct evidence of mesenchymal stem cell tropism for tumor and wounding microenvironments using in vivo bioluminescent imaging,” Stem Cells, vol. 27, no. 10, pp. 2614–2623, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. S. M. Albarenque, R. M. Zwacka, and A. Mohr, “Both human and mouse mesenchymal stem cells promote breast cancer metastasis,” Stem Cell Research, vol. 7, no. 2, pp. 163–171, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. E. Eggenhofer, V. Benseler, A. Kroemer et al., “Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusion,” Frontiers in Immunology, vol. 3, article 297, Article ID Article 297, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Schrepfer, T. Deuse, H. Reichenspurner, M. P. Fischbein, R. C. Robbins, and M. P. Pelletier, “Stem cell transplantation: the lung barrier,” Transplantation Proceedings, vol. 39, no. 2, pp. 573–576, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Quan, M. K. Cho, Y. Shao et al., “Dermal fibroblast expression of stromal cell-derived factor-1 (SDF-1) promotes epidermal keratinocyte proliferation in normal and diseased skin,” Protein and Cell, vol. 6, no. 12, pp. 890–903, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. S.-B. Zhou, J. Wang, C.-A. Chiang, L.-L. Sheng, and Q.-F. Li, “Mechanical stretch upregulates SDF-1α in skin tissue and induces migration of circulating bone marrow-derived stem cells into the expanded skin,” Stem Cells, vol. 31, no. 12, pp. 2703–2713, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. M. F. Pittenger and B. J. Martin, “Mesenchymal stem cells and their potential as cardiac therapeutics,” Circulation Research, vol. 95, no. 1, pp. 9–20, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. A. F. Wise, T. M. Williams, M. B. G. Kiewiet et al., “Human mesenchymal stem cells alter macrophage phenotype and promote regeneration via homing to the kidney following ischemia-reperfusion injury,” American Journal of Physiology—Renal Physiology, vol. 306, no. 10, pp. F1222–F1235, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. Yao, J. Huang, Y. Geng et al., “Paracrine action of mesenchymal stem cells revealed by single cell gene profiling in infarcted murine hearts,” PLoS ONE, vol. 10, no. 6, Article ID e0129164, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. J.-B. Michel, “Anoïkis in the cardiovascular system: known and unknown extracellular mediators,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 23, no. 12, pp. 2146–2154, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. J. L. Spees, C. A. Gregory, H. Singh et al., “Internalized antigens must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy,” Molecular Therapy, vol. 9, no. 5, pp. 747–756, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. O. Honmou, K. Houkin, T. Matsunaga et al., “Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke,” Brain, vol. 134, no. 6, pp. 1790–1807, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. F. Tögel, Y. Yang, P. Zhang, Z. Hu, and C. Westenfelder, “Bioluminescence imaging to monitor the in vivo distribution of administered mesenchymal stem cells in acute kidney injury,” American Journal of Physiology—Renal Physiology, vol. 295, no. 1, pp. F315–F321, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. D. G. Halme and D. A. Kessler, “FDA regulation of stem-cell-based therapies,” New England Journal of Medicine, vol. 355, no. 16, pp. 1730–1735, 2006. View at Publisher · View at Google Scholar · View at Scopus